Adipose insulin resistance is associated with cardiovascular risk factors in polycystic ovary syndrome

被引:21
作者
Mu, L. [1 ,2 ,3 ,4 ]
Li, R. [1 ,2 ,3 ]
Lai, Y. [1 ,5 ]
Zhao, Y. [1 ,2 ,4 ]
Qiao, J. [1 ,2 ,3 ,4 ,5 ]
机构
[1] Peking Univ, Dept Obstet & Gynecol, Ctr Reprod Med, Hosp 3, 49 North HuaYuan Rd, Beijing 100191, Peoples R China
[2] Natl Clin Res Ctr Obstet & Gynecol, Beijing 100191, Peoples R China
[3] Beijing Key Lab Reprod Endocrinol & Assisted Repr, Beijing 100191, Peoples R China
[4] Minist Educ, Key Lab Assisted Reprod, Beijing 100191, Peoples R China
[5] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China
基金
中国国家自然科学基金;
关键词
Polycystic ovary syndrome; Adipose tissue; Insulin resistance; Metabolic syndrome; GLUCOSE-PRODUCTION; INFLAMMATION; PREVALENCE; OBESE; PATHOPHYSIOLOGY; SENSITIVITY; STRESS; WOMEN;
D O I
10.1007/s40618-018-0949-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PurposeThe effects of adipose insulin resistance on cardiovascular risk factors in polycystic ovary syndrome (PCOS) remain largely unknown. We aimed to investigate associations between adipose insulin resistance and cardiovascular risk factors in PCOS.MethodsA total of 207 PCOS and 47 non-PCOS women were recruited from a large reproductive medicine center in this cross-sectional study. The PCOS diagnosis was based on the Rotterdam Criteria. The subjects received a standard oral glucose tolerance test. Adipose insulin resistance was evaluated using a validated index (adipose-IR=fasting insulinxfree fatty acid concentrations).ResultsThe women with PCOS showed a higher adipose-IR index, and the adipose-IR index was tightly associated with the blood pressure, glucose and lipid parameters. A total of 98.0% of the women with PCOS in the highest adipose-IR quartile showed cardiovascular risk factors (obesity, hypertension, glucose intolerance or dyslipidemia), and this percentage was significantly higher than the percentage of those in the lowest quartile (32.7%). In addition, the percentages of women with three (31.4%) and four (13.7%) cardiovascular risk factors were significantly elevated in the highest adipose-IR quartile. The multivariable logistic regression analysis indicated that each 1-SD increment in the adipose-IR index resulted in higher risks of obesity (OR=3.18, 95% CI=2.12-4.76), hypertension (OR=1.89, 95% CI=1.31-2.73), glucose intolerance (OR=2.45, 95% CI=1.73-3.48), and dyslipidemia (OR=2.18, 95% CI=1.57-3.01). The C-reactive protein (CRP) level was positively associated with the adipose-IR index in women with PCOS (r=0.45, P<0.001).ConclusionsThe adipose-IR index was associated with cardiovascular risk factors in women with PCOS. Chronic inflammation may induce insulin resistance in the adipose tissue of women with PCOS.
引用
收藏
页码:541 / 548
页数:8
相关论文
共 50 条
  • [41] Biomediators in Polycystic Ovary Syndrome and Cardiovascular Risk
    Pandurevic, Srdan
    Macut, Djuro
    Fanelli, Flaminia
    Pagotto, Uberto
    Gambineri, Alessandra
    BIOMOLECULES, 2021, 11 (09)
  • [42] Polycystic ovary syndrome and insulin resistance
    Ducluzeau, PH
    Laville, M
    Vidal, H
    Pugeat, M
    DIABETES & METABOLISM, 2001, 27 (04) : S7 - S12
  • [43] Insulin resistance and polycystic ovary syndrome
    Galluzzo, Aldo
    Amato, Marco Calogero
    Giordano, Carla
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2008, 18 (07) : 511 - 518
  • [44] Cardiovascular risk and events in polycystic ovary syndrome
    Carmina, E.
    CLIMACTERIC, 2009, 12 : 22 - 25
  • [45] The effects of insulin sensitizers on the cardiovascular risk factors in women with polycystic ovary syndrome
    E. Kassi
    E. Diamanti-Kandarakis
    Journal of Endocrinological Investigation, 2008, 31 : 1124 - 1131
  • [46] The effects of insulin sensitizers on the cardiovascular risk factors in women with polycystic ovary syndrome
    Kassi, E.
    Diamanti-Kandarakis, E.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2008, 31 (12) : 1124 - 1131
  • [47] Cardiometabolic Risk Factors in Adolescents with Polycystic Ovary Syndrome
    Vatopoulou, Anastasia
    Dionelli, Maria-Eleni
    Papanikolaou, Alexis
    Grover, Sonia
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (36) : 3808 - 3811
  • [48] Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
    Beata Seeber
    Elisabeth Morandell
    Fabian Lunger
    Ludwig Wildt
    Hans Dieplinger
    Reproductive Biology and Endocrinology, 12
  • [49] Cardiovascular disease risk in the siblings of women with polycystic ovary syndrome
    Karthik, Subramaniam
    Vipin, V. P.
    Kapoor, Aditya
    Tripathi, Archana
    Shukla, Manoj
    Dabadghao, Preeti
    HUMAN REPRODUCTION, 2019, 34 (08) : 1559 - 1566
  • [50] Adipose Insulin Resistance in Normal-Weight Women With Polycystic Ovary Syndrome
    Dumesic, Daniel A.
    Phan, Julia D.
    Leung, Karen L.
    Grogan, Tristan R.
    Ding, Xiangmiang
    Li, Xinmin
    Hoyos, Luis R.
    Abbott, David H.
    Chazenbalk, Gregorio D.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (06) : 2171 - 2183